Conditions of Issue. The Conditions and other provisions contained in the Schedules shall be deemed to be incorporated in this Instrument and the Notes shall be held subject to and with the benefit of the Conditions and of those provisions, all of which shall be binding on the Company and the Noteholders and all persons claiming through or under them respectively. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.
Appears in 6 contracts
Samples: Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bgs649 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bgs649 Asset Purchase Agreement (Mereo Biopharma Group PLC)
Conditions of Issue. The Conditions and other provisions contained in the Schedules shall be deemed to be incorporated in this Instrument and the Notes shall be held subject to and with the benefit of the Conditions and of those provisions, all of which shall be binding on the Company and the Noteholders and all persons claiming through or under them respectively. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions.
Appears in 3 contracts
Samples: Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC)
